Value Bridge — OZARKS MEDICAL CENTER
Current $-7M → Target $-4M (+$3.2M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-7.3M
Current EBITDA
$-4.1M
Target EBITDA
+$3.2M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$0.7M
Payer Mix Optimization
$1.7M
Cost to Collect Reduction
$0.6M
Clean Claim Improvement
$0.4M
Volume & Rate Growth
$2.9M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-7M to $-4M. The highest-impact lever is Volume & Rate Growth at $1.2M probability-weighted.
IC talking point: "We see $3M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $35M in equity value creation."